Searchable abstracts of presentations at key conferences in endocrinology

ea0045p69 | Pituitary and growth | BSPED2016

Changes in Height and IGF-I SDS in the first year of GH treatment are related to BMI SDS

Price Victoria , Blair Jo , Hawcutt Dan

Background: During childhood, growth hormone (GH) doses are usually calculated using total body weight (TBW). This may result in inappropriately high doses in obese children where the intravascular compartment does not increase in proportion with the increase in weight, as the volume of distribution of GH is consistent with the majority of the drug being distributed in the total body water compartment.Methods: Single centre, retrospective cohort study of...